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Hydrostannylation–Cross-Coupling Strategy for Stereoselective 
Synthesis of Alkylidenemalonates and Related !,"-Unsaturated 
Esters 
Shinichi Fujiwara,[a] Romain Cadou,[a] Yousuke Yamaoka,[a] Kiyosei Takasu,[a] and Ken-ichi Yamada*[a] 
 
Abstract: A method for stereoselective syntheses of 
alkylidenemalonates and related !,"-unsaturated esters via a 
hydrostannylation–cross-coupling process has been developed. Pd-
catalyzed and radical hydrostannylation of propiolate derivatives 
stereoselectively provided !-alkoxycarbonyl (E)- and (Z)-
vinylstannanes, respectively, which were then converted into 
alkylidenemalonates by the Stille coupling reaction. A one-pot 
process was also realizable for the Pd-catalyzed reactions. 
Introduction 
Doubly activated olefins, such as alkylidenemalonates and !-
alkylidene "-keto esters, are useful compounds and are often 
utilized as powerful Michael acceptors[ 1 ] or highly reactive 
dienophiles[ 2 ] in cycloaddition reactions. The Knoevenagel 
condensation, which is the addition of an active methylene 
compound to an aldehyde followed by dehydration, is the most 
widely used method for the preparation of this class of 
compounds.[3] However, this reaction is generally inapplicable to 
E/Z-selective syntheses of olefins bearing two different electron-
withdrawing groups, giving a mixture of the isomers depending 
on their thermodynamic stability.[ 4 ] To construct the desired 
stereochemistry in a stereospecific cycloaddition reaction,[2] it is 
important to prepare substrates E/Z-selectively. Furthermore, 
the Knoevenagel condensation is commonly conducted in the 
presence of acid and base catalysts at high temperatures; 
therefore, the reactions with easily enolizable aldehydes, such 
as 2-arylalkanals, are often problematic.[5,6] These limitations led 
us to develop a stereoselective synthesis of doubly activated 
olefins from alkynes using hydrometallation followed by cross-
coupling. 
Our strategy is shown in Scheme 1. Regio- and 
stereoselective hydrometallation of alkyne 1, bearing an 
electron-withdrawing group, gives the metallated alkene 2 or 4. 
The subsequent transition metal-catalyzed cross-coupling 
reaction selectively produces the E/Z-isomers of doubly 
activated olefins 3 and 3'. Since both stereoselective 
hydrostannylation[7] and acylation of !-stannyl !,"-unsaturated 
carbonyl compounds by cross-coupling[8] have been reported 
separately, we chose tin as the metal component to prove the 
validity of the concept. Herein, we report a method for the 
stereoselective synthesis of both isomers of 
alkylidenemalonates and related !,"-unsaturated esters under 
































Scheme 1. Hydrometallation–cross-coupling strategy to selectively obtain (E)- 
and (Z)-alkylidenemalonates. 
Results and Discussion 
We first tested the reported condition for acylation of !-stannyl 
!,"-unsaturated carbonyl compounds in the reaction of (E)-
vinylstannane 2a, prepared by Pd-catalyzed hydrostannylation 
of methyl phenylpropiolate (vide infra), with isobutyl 
chloroformate. A solution of 2a and isobutyl chloroformate in 
HMPA was stirred in the presence of Pd(dba)2 (5 mol %) at 
100 °C.[8a] Although 2a disappeared after 12 h by TLC 
monitoring, the expected (E)-benzylidenemalonate 3ab was 
obtained only in 5% yield with unidentified byproducts (Scheme 
2). Thus, we decided to explore new conditions. 
 
Ph
SnBu3MeO2C Pd(dba)2 5 mol%
HMPA




  1.0 equiv
 
Scheme 2. The reaction of 2a with ClCO2i-Bu under the condition of ref 8a. 
A mixture of 2a and isobutyl chloroformate (1.5 equiv) in 
toluene was stirred at 100 °C in the presence of palladium 
diacetate (5 mol %) and triphenylphosphine (12.5 mol %). After 9 
h, the expected (E)-benzylidenemalonate 3ab was obtained in 
58% yield; however, a trace amount (<1%) of the stereoisomer 
3ba was observed by 1H NMR of the crude product. It was 
confirmed that the isomerization of 3ab takes place at 100 °C in 
toluene even in the absence of the palladium catalyst and the 
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ligand. The isomerization of the olefinic geometry was 
suppressed when the reaction was conducted at 80 °C, giving 
3ab selectively in 48% yield after 24 h (Table 1, entry 1). The 
retention of the configuration was confirmed by NOESY 
correlations between the methoxy and the aromatic protons, and 
the methyl protons of the isobutoxy group and the vinylic proton 
of 3ab. 
 
Table 1. Optimization of reaction conditions.[a] 
2a + ClCO2i-Bu
Pd 5 mol %
ligand 12.5 mol %
3ab
1.5 equiv  
entry Pd source ligand solvent temp time yield[b] 
1 Pd(OAc)2 Ph3P toluene 80 °C 24 h 48% 
2  Pd(OAc)2 Ph3P DMF 80 °C 24 h 0% 
3  Pd(OAc)2 Ph3P MeCN 80 °C 24 h 0% 
4 Pd(OAc)2 Ph3P DCE 80 °C 24 h 62% 
5 Pd(OAc)2 Ph3P DME 80 °C 15 h 75% 
6  PdCl2(PPh3)2 Ph3P DME 80 °C 7 h 0% 
7  PdBn(PPh3)2Cl Ph3P DME 80 °C 7 h 0% 
8 Pd(PPh3)4 none DME 80 °C 24 h 60% 
9 Pd2(allyl)2Cl2 Ph3P DME 80 °C 7 h 80% 
10 Pd2(dba)3#CHCl3 Ph3P DME 80 °C 4 h 83% 
11 Pd2(dba)3#CHCl3 Ph3As DME 80 °C 4 h 51% 
12 Pd2(dba)3#CHCl3 dppe DME 80 °C 4 h 0% 
13 Pd2(dba)3#CHCl3 Ph3P DME 40 °C 24 h 0% 
14 Pd2(dba)3#CHCl3 Ph3P DME 60 °C 24 h 70% 
15[c] Pd2(dba)3#CHCl3 Ph3P DME 80 °C 6 h 83% 
16[d] Pd2(dba)3#CHCl3 Ph3P DME 80 °C 8 h 66% 
[a] Conducted with 0.15 mmol 2a and 1.5 mL solvent. [b] Determined by 1H 
NMR of the crude mixture with Ph3CH as an internal standard. [c] 
Pd2(dba)3#CHCl3 (1.0 mol %), Ph3P (5.0 mol %). [d] Pd2(dba)3#CHCl3 (0.5 
mol %), Ph3P (2.5 mol %). 
 
Significant solvent effects were observed; the reaction in 
DMF gave a complex mixture containing no detectable amount 
of 3ab (entry 2). Although no reaction proceeded in acetonitrile 
(entry 3), the reaction in DCE gave 3ab in 62% yield (entry 4). 
Among the tested solvents, the reaction proceeded most 
smoothly in DME, and 3ab was produced in 75% yield after 15 h 
(entry 5). 
The choice of the palladium source was also important. 
Although the reaction with tetrakis(triphenylphosphine)palladium 
was slower (60% yield after 24 h; entry 8), the use of 
allylpalladium chloride dimer accelerated the reaction to give 
3ab in 80% yield after 7 h (entry 9). Tris(dibenzylideneacetone) 
dipalladium chloroform adduct (Pd2(dba)3#CHCl3) was found to 
be an excellent catalyst for this reaction to produce 3ab in 83% 
yield after 4 h (entry 10). With bis(triphenylphosphine)palladium 
dichloride or benzylbis(triphenylphosphine)palladium chloride, 
no reaction proceeded, and 2a was recovered quantitatively 
(entries 6 and 7). Ligands other than triphenylphosphine, such 
as triphenylarsine[9] and bis(diphenylphosphino)ethane, turned 
out to be less effective (entries 11 and 12). Commonly used 
additives were tested under the conditions of entry 10; however, 
no reaction proceeded in the presence of lithium chloride,[10] and 
the addition of cesium fluoride[11] resulted in decomposition of 2a 
(not shown in the table). 
To our delight, the efficient reaction rate was maintained with 
2 mol % palladium catalyst to give 3ab in 83% yield after 6 h 
(entry 15). Further decrease of the catalyst loading (1 mol %) or 
lower reaction temperatures (40 or 60 °C), however, resulted in 
significant deceleration of the reaction (entries 16, 13 and 14). 
With the best conditions for the cross-coupling reaction in 
hand (Table 1, entry 10), the substrate scope was investigated. 
Not only with propiolate derivatives, but also with propiolamide 
and propiolonitrile derivatives, the Pd-catalyzed regio- and 
stereoselective hydrostannylation proceeded under modified 
conditions,[7a] giving (E)-vinylstannanes 2 in 64–83% yield (Table 
2).[7b,12,13] The conditions for the cross-coupling were compatible 
with various functional groups, such as esters (entries 1–3), an 
amide (entry 4), and a cyanide (entry 5), to give the products 3 
in 67–89% yield. Substrates bearing either an electron-rich or 
electron-deficient aromatic ring (entries 6–8) as well as an alkyl 
group (entries 9 and 10) gave the products in good yields. It is 
noteworthy that phenethylidenemalonate 3ib, unavailable from 
the Knoevenagel condensation, was prepared without migration 
of the C=C bond (entry 9). Moreover, a Cbz group (entry 11) and 
a sterically crowded menthyloxy- or 8-phenylmenthyloxycarbonyl 
group (entries 12 and 13) could also be introduced to 2a to give 
the corresponding benzylidenemalonates 3ac, 3ak, and 3al, 
respectively, in good yields. 
 






Pd2(dba)3·CHCl3 2.5 mol %









Pd(OAc)2 2 mol %
Ph3P 5 mol %
THF
0 °C, 0.5 h  
entry 1 R1 EWG 2 yield R2 3 time h yield
[a] 
1[b] 1a Ph CO2Me 2a 69% i-Bu 3ab 6 83% 
2 1b Ph CO2i-Bu 2b 67% Me 3ba 12 72% 
3 1c Ph CO2Bn 2c 72% Me 3ca 12 67% 
4 1d Ph CONMe2 2d 73% i-Bu 3db 12 74% 
5 1e Ph CN 2e 64% i-Bu 3eb 12 89% 
6 1f 4-FC6H4 CO2Me 2f 77% i-Bu 3fb 12 90% 






7 1g 4-MeOC6H4 CO2Me 2g 73% i-Bu 3gb 12 76% 
8 1h 2-MeC6H4 CO2Me 2h 68% i-Bu 3hb 12 70% 
9 1i Bn CO2Me 2i 69%[c] i-Bu 3ib 12 57%[d] 
10 1j hexyl CO2Me 2j 83% i-Bu 3jb 12 79% 
11 1a Ph CO2Me 2a 69% Bn 3ac 12 61% 
12 1a Ph CO2Me 2a 69% Men[e] 3ak 12 89% 
13[f] 1a Ph CO2Me 2a 69% !Men[e] 3al 24 75% 
[a] Isolated yield. [b] Pd2(dba)3#CHCl3 (1 mol %), Ph3P (5 mol %). [c] Including 
9% impurity. Yield was estimated with 1H NMR (see Experimental Section). [d] 
Based on two-step yield and the estimated yield of 2i. [e] Men = menthyl, 
$Men = 8-phenylmenthyl. [f] ClCO2R2 (2.0 equiv). 
 
The reaction of (Z)-vinylstannane was also investigated. 
Following a report on radical hydrostannylation,[7c] (Z)-
vinylstannane 4a was prepared stereo- and regioselectively in 
69% yield by using AIBN and tributylstannane.[12] The geometry 
of the vinylstannane clearly affected the reaction time and yield; 
the reaction of 4a with isobutyl, menthyl, and 8-phenylmenthyl 
chloroformate under the optimized conditions for 2a required 
longer reaction time (24 h) and gave lower yields (45–48%; 
Table 3, entries 1–3) than the reactions of 2a (75–89%; Table 2, 
entries 1, 12, and 13). Comparable results are likely to be 
obtained from the same reaction sequence with propiolates 1f–h, 
which bear substituted benzene rings.[7c] Unfortunately, 
propiolate 1j, bearing an alkyl group, propiolamide 1d, and 
propiolonitrile 1e were inapplicable because the radical 
hydrostannylation step resulted in a complex mixture (1j and 1e) 
or recovery of the starting material (1d). 
 




Pd2(dba)3·CHCl3 2.5 mol %
Ph3P 12.5 mol %
DME







entry R 3 yield[a] 
1 i-Bu 3ba 48% 
2 Men[b] 3ka 48% 
3 !Men[b] 3la 45% 
4 Bn 3ca trace 
[a] Isolated yield. [b] Men = menthyl, $Men = 8-phenylmenthyl. 
 
The retention of the configuration was confirmed by NOESY 
experiments of 3ba, showing correlation between the methyl 
protons of the isobutoxy group and the aromatic protons. 
Nevertheless, it is noteworthy that the desired malonates were 
obtained in geometrically pure form, since isomerization of (Z)-
vinylstannane to the (E)-isomers under cross-coupling 
conditions was previously reported.[8a,14] The reaction with benzyl 
chloroformate only gave a trace amount of the desired 3ca 
(Table 3, entry 4), probably due to low reactivity of 4a as well as 
thermal instability of the chloroformate. The observed lower 
reactivity of (Z)-stannane 4a is likely attributed to the steric 
hindrance of the adjacent phenyl group. Alternatively, the same 
products can be obtained in better yields from (E)-vinylstannane 
by exchanging the electron-withdrawing groups of the two 
reaction partners (2 and chloroformate) (e.g., Table 2, entries 1 
and 2, and 3 and 11). 
The developed hydrostannylation–cross-coupling sequence 
was performable in one-pot (Scheme 3). A solution of 1a and 
tributylstannane (1.1 equiv) was stirred at 0 °C in the presence 
of Pd2(dba)3.CHCl3 and triphenylphosphine (2.5 and 12.5 mol %, 
respectively). When complete consumption of 1a was confirmed 
by TLC monitoring after 0.5 h, the solution was warmed up to 
80 °C, and isobutyl chloroformate (1.5 equiv) was added to the 
solution. After 12 h, 3ab was obtained in a better yield (68%) 
than the overall yield of the sequential reactions (Table 2, entry 
1). To realize the efficient one-pot reaction, the amount of the 
stannane was important; when an excess amount of the 
stannane (1.5 equiv) was used in the hydrostannylation step, the 
coupling reaction was retarded, and ca. 30% of 2a remained 
after 12 h. Propiolates 1m and 1n, which bear secondary and 
tertiary alkyl groups, respectively, were also applicable, and the 
corresponding (E)-alkyldenemalonates 3mb and 3nb were 
obtained in good overall yields (63% and 45%, respectively) 































Scheme 3. One-pot Pd-catalyzed hydrostannylation–cross-coupling. 
Finally, (E)- and (Z)-alkylidenemalonates 3ac and 3ca, 
bearing two different ester moieties, were subjected to the 
reported copper-catalyzed [3+2] cycloaddition (Scheme 4).[15] A 
solution of 3ac and glycine derivative 5 was stirred at rt in the 
presence of copper diacetate (10 mol %), potassium carbonate 
(2 equiv), and MS 4Å. After 12 h, pyrrolidine 6 was obtained in 
92% yield as a 64:36 mixture of the diastereomers at the 
stereogenic center on the quaternary carbon. This result 
indicates that this cycloaddition proceeded mainly via stepwise 
bond formation and not via a concerted mechanism proposed in 
the literature. In turn, the reaction of 3ca gave 6 with 33:67 
diastereomeric ratio (dr). Therefore, the diastereoselectivity of 
the cycloaddition partially reflected the stereochemistry of the 
malonates utilized. The irreversibility of the cycloaddition 
reaction was confirmed by the following experiments. When 6 
with dr 64:36 and 33:67 were each treated with the above 
reaction conditions for 12 h, no epimerization of 6 occurred, 
recovering 6 with unchanged dr. Accordingly, in this step-wise 






cycloaddition, the rate constant of the cyclization of intermediate 
A (kadd) should be competitive with that of the indicated C–C 
bond rotation (krot).[ 16 ] This clearly exemplifies the utility of 
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Scheme 4. Copper-catalyzed [3+2] cycloaddition of 3ac and 3ca, shedding 
light on the mechanism. 
Conclusions 
We developed a stereo- and regioselective synthesis of doubly 
activated olefins, using hydrostannylation of alkynes bearing an 
electron-withdrawing group, and a subsequent cross-coupling 
reaction. Alkylidenemalonates, as well as !-carbamoyl- and !-
cyano-!,"-unsaturated esters were stereoselectively prepared 
by this method. The mild and neutral reaction conditions allowed 
us to prepare such esters bearing various functional groups, and 
were shown to be desirable especially for olefins that easily 
undergo isomerization, such as phenethylidenemalonate. This 
new methodology is a favorable option even for substrates that 
are unsuitable for the conventional Knoevenagel condensation. 
The extension of this methodology utilizing other cross-coupling 
reactions is underway in this laboratory. 
Experimental Section 
General. All the reactions were performed under argon atmosphere. 
Anhydrous solvents were purchased and used as reaction solvents. 
Starting materials, reagents and solvents were purchased and used as 
supplied unless otherwise noted. Silica gel was used for column 
chromatography unless otherwise noted. NMR (500 MHz for 1H and 125 
MHz for 13C) was measured in CDCl3. Chemical shifts and coupling 
constants (J) are presented in ppm % relative to tetramethylsilane and Hz, 
respectively. Abbreviations are as follows: s, singlet; d, doublet; t, triplet; 
q, quartet; m, multiplet; br, broad. 13C peak multiplicity assignments were 
made based on DEPT data. 13C–117Sn and 13C–119Sn coupling constants 
of satellite peaks in 13C NMR are not reported for clarity. For confirmation 
of E/Z-geometry of 2 and 4, average of 1H–117Sn and 1H–119Sn coupling 
constants, usually differing by 1–3 Hz,[13] were reported as H–Sn 
coupling constants due to insufficient resolution. The wave numbers of 
maximum absorption peaks of IR spectroscopy are presented in cm–1. A 
quadrupole mass spectrometer was used for EIMS, while ESIMS was 
measured with TOF. 
Preparation of Starting Materials. Chloroformates were purified by 
distillation before use. Alkynes 1c,[18] 1d,[19]1e,[20] 1f,[21] 1g,[22] 1h,[23] and 
1i;[24] and imine 5[15] were prepared according to the literature. 
Isobutyl 3-Phenylpropiolate (1b): Phenylacetylene (1.1 mL, 10 mmol) 
was dissolved in THF (10 mL) in a dry 50-mL round-bottom flask. To the 
stirred solution cooled at –78 °C, a 1.6 M hexane solution of BuLi (6.4 mL, 
10 mmol) and ClCO2Me (1.5 mL, 20 mmol) were dropwise added at 30 
min interval. After 10 min, the cooling bath was removed, and the mixture 
was stirred for additional 30 min. After addition of sat. aq NaHCO3, the 
whole was extracted twice with AcOEt, and the combined organic layers 
were washed with brine, dried over Na2SO4, and concentrated in vacuo. 
The residue was purified by column chromatography (hexane to 
hexane/AcOEt 10:1) to afford the title compound (2.05 g, 98%) as a pale 
yellow oil: 1H NMR: 7.55–7.65 (m, 2H), 7.45 (m, 1H), 7.35–7.40 (m, 2H), 
4.03 (d, J = 7.0, 2H), 2.05 (m, 1H), 0.99 (d, J = 6.5, 6H). 13C NMR: 154.1 
(C), 132.9 (CH), 130.5 (CH), 128.5 (CH), 119.6 (C), 86.0 (C), 80.6 (C), 
71.9 (CH2), 27.6 (CH), 18.9 (CH3). IR (neat): 2967, 2936, 2878, 2222, 
1709, 1281, 1188, 1169. EIMS m/z: 202 (M+), 146 (M – isobutene), 129 
(M – i-BuO). 1H NMR, 13C NMR, IR and EIMS data were in good 
agreement with published data.[25] 
Methyl 4-methylpent-2-ynoate (1m): 3-methyl-1-butyne (2.0 mL, 20 
mmol) was dissolved in THF (20 mL) in a dry 50-mL round-bottom flask. 
To the stirred solution cooled at –78 °C, a 1.6 M hexane solution of BuLi 
(14 mL, 22 mmol) and ClCO2Me (1.8 mL, 24 mmol) were dropwise added 
at 30 min interval. After 10 min, the cooling bath was removed, and the 
mixture was stirred for additional 30 min. After addition of sat. aq 
NaHCO3, the whole was extracted twice with Et2O, and the combined 
organic layers were washed with brine, dried over Na2SO4, and 
concentrated in vacuo to afford the title compound (95%) as a pale 
yellow oil, which was used for the next step without further purification.1H 
NMR: 3.75 (s, 3H), 2.70 (septet, J = 7.0, 1H), 1.24 (d, J = 7.0, 6H). 13C 
NMR: 154.3 (C), 94.3 (C), 72.0 (C), 52.4 (CH3), 21.6 (CH3), 20.4 (CH). 1H 
and 13C NMR spectra were in good agreement with published data.[26]  
Methyl 4,4-dimethylpent-2-ynoate (1n): The same procedure as that for 
1m using 3,3-dimethyl-1-butyne (2.5 mL, 20 mmol) in place of 3-methyl-
1-butyne afforded the title compound (95%) as a pale yellow oil, which 
was used for the next step without further purification. 1H NMR: 3.76 (s, 
3H), 1.29 (s, 9H). 13C NMR: 154.4 (C), 96.9 (C), 71.4 (C), 52.5 (CH3), 
31.6 (C), 29.9 (CH3). 1H and 13C NMR spectra were in good agreement 
with published data.[27]  
General Procedure for Pd-Catalyzed Hydrostannylation (Table 2, 
entries 1 and 11–13). (E)-Methyl 3-Phenyl-2-(tributylstannyl)acrylate 
(2a): to avoid the use of Pd(PPh3)4,[7a] Pd(OAc)2 was utilized, instead: 1a 
(1.5 mL, 10 mmol), Pd(OAc)2 (45 mg, 0.20 mmol), and Ph3P (130 mg, 
0.500 mmol) were dissolved in THF (20 mL) in a dry 100-mL round-
bottom flask. To the solution cooled in an ice–water bath, was added 
Bu3SnH (3.3 mL, 12 mmol). The mixture was stirred for 30 min, and the 
cooling bath was removed. The mixture was concentrated in vacuo, and 
the residue was purified by column chromatography (hexane to 
hexane/Et2O 20:1) to afford the title compound (3.21 g, 69%) as a pale 
yellow oil: 1H NMR: 7.29–7.33 (m, 4H), 7.25 (m, 1H), 6.71 (s, 1H), 3.69 (s, 
3H), 1.45–1.65 (m, 6H), 1.34 (sextet, J = 7.5, 6H), 1.06 (t, J = 8.0, 6H), 
0.91 (t, J = 7.5, 9H). 13C NMR: 173.7 (C), 142.2 (CH), 139.4 (C), 137.0 
(C), 128.4 (CH), 128.1 (CH), 127.9 (CH), 51.4 (CH3), 28.8 (CH2), 27.2 
(CH2), 13.7 (CH3), 10.6 (CH2). IR (neat): 2955, 2922, 1703, 1207. EIMS 
m/z: 451 (M+), 395 (M – Bu). Anal. Calcd for C22H36O2Sn: C, 58.56; H, 
8.04. Found: C, 58.53; H, 8.21. The E-geometry was confirmed by the H–
Sn coupling constant of the satellite peaks of the "-H (6.71 ppm, 3JH–Sn = 
59 Hz).[13] 
(E)-Isobutyl 3-Phenyl-2-(tributylstannyl)acrylate (2b): Purified by 
column chromatography (hexane to hexane/Et2O 50:1). From 10-mmol 
1b, the title compound (3.31 g, 67%) was obtained as a pale yellow oil: 
1H NMR: 7.20–7.35 (m, 3H), 6.71 (s, 1H), 3.87 (d, J = 6.5, 2H), 1.88 






(nonet, J = 6.5, 1H), 1.47–1.65 (m, 6H), 1.34 (sextet, J = 7.5, 6H), 1.07 (t, 
J = 8.5, 6H), 0.91 (t, J = 7.5, 9H), 0.84 (d, J = 6.5, 6H). 13C NMR: 173.5 
(C), 142.0 (CH), 139.8 (C), 137.1 (CH), 128.3 (CH), 127.9 (CH), 124.5 
(C), 70.7 (CH2), 28.8 (CH2), 27.6 (CH), 27.3 (CH2), 19.2 (CH3), 13.7 
(CH3), 10.6 (CH2). IR (neat): 2959, 2924, 2874, 2855, 1701, 1173. EIMS 
m/z: 437 (M – Bu). HRMS–ESI (m/z): [M + Na]+ calcd for C25H42O2SnNa, 
517.2099; found, 517.2098. The E-geometry was confirmed by the H–Sn 
coupling constant of the satellite peaks of the "-H (6.71 ppm, 3JH–Sn = 58 
Hz).[13] 
(E)-Benzyl 3-Phenyl-2-(tributylstannyl)acrylate (2c): Purified by 
column chromatography (hexane to hexane/Et2O 50:1). From 0.8-mmol 
1c, the title compound (301 mg, 72%) was obtained as a pale yellow oil: 
1H NMR: 7.34–7.21 (m, 10H), 6.71 (s, 1H), 5.14 (s, 2H), 1.63–1.42 (m, 
6H), 1.38–1.21 (m, 6H), 1.10–0.96 (m, 6H), 0.88 (t, J = 7.0, 9H). 13C 
NMR: 173.0 (C), 142.4 (CH), 139.3 (C), 136.9 (C), 135.8 (C), 128.8 (CH), 
128.4 (CH), 128.3 (CH), 128.1 (CH), 128.0 (CH), 127.9 (CH), 66.3 (CH2), 
28.7 (CH2), 27.2 (CH2), 13.7 (CH3), 10.6 (CH2). IR (KBr): 2955, 2924, 
2870, 2853, 1701, 1375, 1206, 1167. ESIMS m/z: 551 (M + Na).  HRMS–
ESI (m/z): [M + Na]+ calcd for C28H40O2SnNa, 551.1948; found, 551.1947. 
The E-geometry was confirmed by the H–Sn coupling constant of the 
satellite peaks of the "-H (6.71 ppm, 3JH–Sn = 58 Hz).[13] 
(E)-N,N-Dimethyl-3-phenyl-2-(tributylstannyl)acrylamide (2d): Purified 
by column chromatography (hexane to hexane/Et2O 50:1). From 2.5-
mmol 1d, the title compound (851 mg, 73%) was obtained as a pale 
yellow oil: 1H NMR: 7.27–7.31 (m, 4H), 7.22 (m, 1H), 6.57 (s, 1H), 2.95 (s, 
3H), 2.71 (s, 3H), 1.46–1.65 (m, 6H), 1.35 (sextet, J = 7.0, 6H), 1.07 (t, J 
= 7.0, 6H), 0.91 (t, J = 7.0, 9H). 13C NMR: 174.1 (C), 143.2 (CH), 138.0 
(C), 137.5 (C), 128.5 (CH), 127.7 (CH), 127.6 (CH), 37.1 (CH3), 34.2 
(CH3), 28.9 (CH2), 27.3 (CH2), 13.7 (CH3), 10.5 (CH2). IR (neat): 2955, 
2924, 2855, 1717, 1605, 1462, 1254, 1076. EIMS m/z: 465 (M+), 408 (M 
– Bu). HRMS–ESI (m/z): [M + H]+ calcd for C23H40OSn, 466.2126; found, 
466.2125. The E-geometry was confirmed by the H–Sn coupling constant 
of the satellite peaks of the "-H (6.58 ppm, 3JH–Sn = 62 Hz).[13] 
(E)-3-Phenyl-2-(tributylstannyl)acrylonitrile (2e): Purified by column 
chromatography (hexane to hexane/Et2O 50:1). From 1.0-mmol 1e, the 
title compound (269 mg, 64%) was obtained as a pale yellow oil: 1H 
NMR: 7.83 (d, J = 7.0, 2H), 7.35–7.45 (m, 3H), 7.06 (s, 1H), 1.64 (m, 6H), 
1.37 (sextet, J = 7.5, 6H), 1.07 (m, 6H), 0.92 (t, J = 7.5, 9H). 13C NMR: 
156.0 (CH), 136.2 (C), 130.1 (CH), 128.8 (CH), 128.6 (CH), 121.2 (C), 
111.2 (C), 28.6 (CH2), 27.2 (CH2), 13.6 (CH3), 10.9 (CH2). IR (neat): 2955, 
2924, 2855, 2176, 1713, 1585, 1562, 1076, 1049. EIMS m/z: 362 (M 
" Bu), 306 (M " 2Bu). HRMS–ESI (m/z): [M + Na]+ calcd for 
C21H33NSnNa, 442.1527; found, 442.1529. Anal. Calcd for C21H33NSn: C, 
60.31; H, 7.95; N, 3.35. Found: C, 60.56; H, 8.10; N, 3.36. The E-
geometry was confirmed by the H–Sn coupling constant of the satellite 
peaks of the "-H (7.06 ppm, 3JH–Sn = 47 Hz).[13] 
(E)-Methyl 3-(4-Fluorophenyl)-2-(tributylstannyl)acrylate (2f): Purified 
by column chromatography (hexane to hexane/Et2O 50:1). From 1.0-
mmol 1f, the title compound (363 mg, 77%) was obtained as a pale 
yellow oil: 1H NMR: 7.23–7.31 (m, 3H), 6.99 (tt, J = 9.0, 2.0, 2H), 6.66 (s, 
1H), 3.69 (s, 3H), 1.47–1.62 (m, 6H), 1.34 (sextet, J = 7.5, 6H), 1.06 (t, J 
= 8.0, 6H), 0.91 (t, J = 7.5, 9H). 13C NMR: 173.5 (C), 162.4 (d, JF-C = 246, 
C), 141.0 (CH), 139.2 (C), 133.2 (C), 129.6 (CH), 115.3 (d, JF-C = 22, CH), 
51.4 (CH3), 28.7 (CH2), 27.2 (CH2), 13.7 (CH3), 10.6 (CH2). IR (neat): 
2959, 2920, 2847, 2816, 1701, 1601, 1508, 1234, 1157. EIMS m/z: 470 
(M+), 413 (M " Bu). HRMS–ESI (m/z): [M + Na]+ calcd for 
C22H35FO2SnNa, 493.1535; found, 493.1534. The E-geometry was 
confirmed by the H–Sn coupling constant of the satellite peaks of the "-H 
(6.66 ppm, 3JH–Sn = 58 Hz).[13] 
(E)-Methyl 3-(4-Methoxyphenyl)-2-(tributylstannyl) acrylate (2g): 
Purified by column chromatography (hexane to hexane/Et2O 50:1). From 
1.0-mmol 1g, the title compound (352 mg, 73%) was obtained as a pale 
yellow oil: 1H NMR: 7.26 (dt, J = 8.5, 3.0, 2H), 6.83 (dt, J = 8.5, 3.0, 2H), 
6.64 (s, 1H), 3.80 (s, 3H), 3.70 (s, 3H), 1.47–1.64 (m, 6H), 1.34 (sextet, J 
= 7.5, 6H), 1.05 (t, J = 8.0, 6H), 0.90 (t, J = 7.5, 9H). 13C NMR: 173.9 (C), 
159.5 (C), 142.0 (CH), 136.4 (C), 129.7 (C), 129.5 (CH), 113.7 (CH), 55.2 
(CH3), 51.3 (CH3), 28.7 (CH2), 27.2 (CH2), 13.7 (CH3), 10.6 (CH2). IR 
(neat): 2997, 2955, 2924, 2851, 1701, 1508, 1250, 1164, 1034. EIMS 
m/z: 425 (M " Bu). HRMS–ESI (m/z): [M + Na]+ calcd for C23H38O3SnNa, 
505.1735; found, 505.1736. The E-geometry was confirmed by the H–Sn 
coupling constant of the satellite peaks of the "-H (6.64 ppm, 3JH–Sn = 60 
Hz).[13] 
(E)-Methyl 3-o-Tolyl-2-(tributylstannyl)acrylate (2h): Purified by 
column chromatography (hexane to hexane/Et2O 50:1). From 2.5-mmol 
1h, the title compound (685 mg, 68%) was obtained as a yellow oil: 1H 
NMR: 7.21 (d, J = 7.5, 1H), 7.08–7.17 (m, 3H), 6.91 (s, 1H), 3.58 (s, 3H), 
2.32 (s, 3H), 1.47–1.64 (m, 6H), 1.34 (sextet, J = 7.5, 6H), 1.06 (t, J = 8.0, 
6H), 0.91 (t, J = 7.5, 9H). 13C NMR: 173.2 (C), 143.1 (CH), 139.8 (C), 
137.0 (C), 135.4(C), 129.9 (CH), 127.9 (CH), 127.6 (CH), 125.7 (CH), 
51.2 (CH3), 28.8 (CH2), 27.2 (CH2), 19.8 (CH3), 13.7 (CH3), 10.6 (337, 
CH2). IR (neat): 2955, 2928, 1701, 1196. EIMS m/z: 465 (M+), 409 (M – 
Bu). Anal. Calcd for C23H38O2Sn: C, 59.37; H, 8.23. Found: C, 59.55; H, 
8.31. The E-geometry was confirmed by the H–Sn coupling constant of 
the satellite peaks of the "-H (6.91 ppm, 3JH–Sn = 55 Hz).[13] 
(E)-Methyl 4-Phenyl-2-(tributylstannyl)but-2-enoate (2i): Purified by 
column chromatography (hexane to hexane/Et2O 50:1). From 2.5-mmol 
1i, a mixture of the title compound (69%) and an impurity (6%) was 
obtained as a pale yellow oil (878 mg): 1H NMR: 7.30 (td, J = 8.0, 2.0, 
2H), 7.22 (dd, J = 8.0, 2.0, 2H), 7.17 (t, J = 8.0, 1H), 7.14–7.33 (m, 0.54H 
impurity), 6.16 (t, J = 7.0, 1H), 4.29 (s, 0.18H impurity), 3.76 (d, J = 7.0, 
2H), 3.74 (s, 3H), 3.70 (s, 0.27H impurity), 1.38–1.57 (m, 6H), 1.24–1.32 
(m, 6H + 0.54H impurity), 1.16–1.24 (m, 0.54H impurity) 0.82–1.16 (m, 
15H + 0.81H impurity), 0.61–0.80 (m, 0.54H impurity). 13C NMR: 171.7 
(C), 150.3 (CH), 139.8 (C), 136.4 (C), 128.8 (CH), 128.5 (CH), 126.1 
(CH), 51.3 (CH3), 38.5 (CH2), 28.9 (CH2), 27.2 (CH2), 13.7 (CH3), 10.3 
(CH2). IR (neat): 2955, 2924, 2851, 1709, 1597, 1192. EIMS m/z: 409 (M 
" Bu). HRMS–ESI (m/z): [M + Na]+ calcd for C23H38O2SnNa, 489.1786; 
found, 489.1786. The E-geometry was confirmed by the H–Sn coupling 
constant of the satellite peaks of the "-H (6.16 ppm, 3JH–Sn = 56 Hz).[13] 
The impurity was assigned as regioisomer, (E)-methyl 4-phenyl-3-
(tributylstannyl)but-2-enoate by analogy with the previous report.[8a] The 
yield was determined by the integration area of 1H NMR signals at 4.29 
and 6.16 ppm. The mixture was used in the next reaction without further 
purification. 
(E)-Methyl 2-(Tributylstannyl)non-2-enoate (2j): Purified by column 
chromatography (hexane to hexane/Et2O 50:1). From 2.5-mmol 1j, the 
title compound (955 mg, 83%) was obtained as a pale yellow oil: 1H 
NMR: 6.04 (t, J = 7.0, 1H), 3.69 (s, 3H), 2.40 (q, J = 7.0, 2H), 1.37–1.53 
(m, 8H), 1.25–1.35 (m, 12H), 0.85–1.04 (m, 18H). 13C NMR: 171.8 (C), 
153.7 (CH), 135.2 (C), 51.1 (CH3), 32.2 (CH2), 31.6 (CH2), 29.2 (CH2), 
28.86 (CH2), 28.85 (CH2), 27.2 (CH2), 22.6 (CH2), 14.1 (CH2), 13.7 (CH3), 
10.2 (CH2). IR (neat): 2955, 2924, 2855, 1709, 1601, 1462, 1177. EIMS 
m/z: 403 (M " Bu). The E-geometry was confirmed by the H–Sn coupling 
constant of the satellite peaks of the "-H (6.04 ppm, 3JH–Sn = 60 Hz).[13] 
1H NMR, 13C NMR, IR, and MS were in good agreement with the 
published data.[28] 
General Procedure for Cross-Coupling Reaction (Table 2, entry 11). 
(E)-Benzyl Methyl Benzylidenemalonate (3ac): 2a (225 mg, 0.500 
mmol), Pd2(dba)3#CHCl3 (13 mg, 2.5 mol %), Ph3P (16 mg, 12.5 mol %), 






and ClCO2i-Bu (0.10 mL, 0.75 mmol) were dissolved in DME (5 mL) in a 
dry 30-mL round-bottom flask. The solution was stirred at 80 °C for 12 h. 
After addition of H2O, the mixture was cooled to rt and extracted with 
AcOEt twice. The combined organic layers were washed with brine, dried 
over Na2SO4, and concentrated in vacuo. The residue was purified by 
column chromatography (hexane/Et2O 50:1 to 10:1) to give the title 
compound (90 mg, 61%) as a pale yellow oil: 1H NMR: 7.79 (s, 1H), 
7.44–7.31 (m, 10H), 5.30 (s, 2H), 3.83 (s, 3H). 13C NMR: 167.0 (C), 
163.9 (C), 143.1 (CH), 135.5 (C), 132.7 (C), 130.7 (CH), 129.4 (CH), 
128.9 (CH), 128.6 (CH), 128.3 (CH), 127.9 (CH), 125.6 (C), 67.2 (CH2), 
52.7 (CH3). IR (neat): 2978, 2947, 2886, 1732, 1620, 1504, 1458, 1373, 
1258, 122, 1053. ESIMS m/z: 319 (M + Na). HRMS–ESI (m/z): [M + Na]+ 
calcd for C18H16O4Na, 319.0941; found, 319.0945. 1H and 13C NMR are 
in good agreement with those reported.[4b] 
(E)-Isobutyl Methyl 2-Benzylidenemalonate (3ab). Step-wise 
Procedure (Table 2, entry 1): according to the General Procedure using 
1.00-mmol 2a with Pd2(dba)3#CHCl3 (10 mg, 1.0 mol %), Ph3P (13 mg, 
5.0 mol %), ClCO2i-Bu (0.20 mL, 1.5 mmol), and DME (10 mL) for 6 h, 
the title compound (226 mg, 83%) was obtained as a pale yellow oil after 
purification by column chromatography (hexane to hexane/AcOEt 10:1). 
One-pot Procedure (Scheme 3): 1a (0.15 mL, 1.0 mmol), 
Pd2(dba)3#CHCl3 (26 mg, 2.5 mol %), and Ph3P (32 mg, 12.5 mol %) 
were dissolved in DME (2 mL) in a dry 30-mL round-bottom flask under 
argon atmosphere. To the stirred solution cooled in an ice–water bath, 
was added Bu3SnH (0.30 mL, 1.1 mmol). After 30 min, the solution was 
warmed up to 80 °C, and isobutyl chloroformate (0.20 mL, 1.5 mmol) was 
added to the solution. After 12 h, H2O was added, and the mixture was 
cooled to rt. The whole was extracted twice with AcOEt, and the 
combined organic layers were washed with brine, dried over Na2SO4, 
and concentrated in vacuo. The residue was purified by column 
chromatography (hexane/Et2O 50:1 to 10:1) to give the title compound 
(182 mg, 68%) as a pale yellow oil: 1H NMR: 7.75 (s, 1H), 7.30–7.50 (m, 
5H), 4.04 (d, J = 7.0, 2H), 3.85 (s, 3H), 2.01 (nonet, J = 7.0, 1H), 0.97 (d, 
J = 7.0, 6H). 13C NMR: 167.2 (C), 164.0 (C), 142.4 (CH), 132.8 (C), 130.6 
(CH), 129.4 (CH), 128.9 (CH), 125.9 (C), 71.5 (CH2), 52.6 (CH3), 27.7 
(CH), 18.9 (CH3). IR (neat): 2961, 1724, 1630, 1260, 1219, 1200, 1082, 
1061. EIMS m/z: 262 (M+), 206 (M – i-Bu), 189 (M – i-BuO). HRMS–ESI 
(m/z): [M + H]+ calcd for C15H19O4, 263.1278; found, 263.1276. The (E)-
geometry was confirmed by NOESY correlations between the methoxy 
and the aromatic protons (3.85 and 7.30–7.50 ppm, respectively), and 
the methyl protons of the isobutoxy group (0.97 ppm) and the vinylic 
proton (7.75 ppm). 
(E)-((1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl) Methyl 2-
Benzylidenemalonate (3ak): Purified by column chromatography 
(hexane/Et2O 50:1 to 10:1). From 0.5-mmol 2a, the title compound (171 
mg, 89%) was obtained as a pale yellow oil: 1H NMR: 7.72 (s, 1H), 7.42–
7.46 (m, 2H), 7.34–7.40 (m, 3H), 4.82 (td, J = 11.0, 4.5, 1H), 3.83 (s, 3H), 
2.10 (ddt, J = 1,0, 12.0, 4.0, 1H), 1.92 (d septet, J = 3.0, 7.0, 1H), 1.70 
(ddd, J = 15.0, 5.0, 2.0, 2H), 1.52 (m, 1H), 1.44 (ddt, J = 12.0, 11.0, 3.0, 
1H), 1.03–1.14 (m, 2H), 0.92 (d, J = 6.5, 3H), 0.91 (d, J = 7.0, 3H), 0.87 
(m, 1H), 0.79 (d, J = 7.0, 3H). 13C NMR: 167.2 (C), 163.6 (C), 142.1 (CH), 
132.9 (C), 130.5 (CH), 129.3 (CH), 128.8 (CH), 126.3 (C), 75.8 (CH), 
52.4 (CH3), 47.1 (CH), 40.6 (CH2), 34.1 (CH2), 31.4 (CH), 26.2 (CH), 23.4 
(CH3), 22.0 (CH3), 20.8 (CH3), 16.3 (CH3). IR (neat): 2955, 2928, 2870, 
1713, 1628, 1258, 1200, 1157. EIMS m/z: 344 (M+), 313 (M – OMe). 
HRMS–ESI (m/z): [M + Na]+ calcd for C20H28O4Na, 367.1880; found, 
367.1880. [#]25D –26.2 (c 1.00, CHCl3). The (E)-geometry was assigned 
by analogy. 
(E)-Methyl ((1R,2S,5R)-(2-Phenylpropan-2-yl)-5-methylcyclohexyl) 2-
Benzylidenemalonate (3al): Purified by column chromatography 
(hexane/Et2O 50:1 to 10:1). From 2.2-mmol 2a, the title compound (698 
mg, 75%) was obtained as a pale yellow oil: 1H NMR: 7.38–7.36 (m, 3H), 
7.34–7.26 (m, 4H), 7.24 (dt, J = 8.0, 1.5, 2 H), 7.06 (s, 1H), 6.99 (tt, J = 
7.0, 1.5, 1H), 4.99 (td, J = 10.5, 4.5, 1H), 3.82 (s, 3H), 2.07 (ddd, J = 12.5, 
10.5, 3.0, 1H), 1.99 (dtd, J = 10.5, 4.0, 1.5, 1H), 1.67–1.59 (m, 2H), 1.50 
(m, 1H), 1.34 (s, 3H), 1.25 (s, 3H), 1.16–1.02 (m, 2H), 0.88 (d, J = 7.5, 
3H). 13C NMR: 167.0 (C), 163.1 (C), 151.1 (C), 141.7 (CH), 132.9 (C), 
130.3 (CH), 129.3 (CH), 128.7 (CH), 128.0 (CH), 126.0 (C), 125.4 (CH), 
125.1 (CH), 76.0 (CH), 52.4 (CH3), 50.6 (CH), 41.6 (CH2), 39.8 (C), 34.4 
(CH2), 31.3 (CH), 26.82 (CH), 26.77 (CH2), 26.3 (CH3), 21.7 (CH3). IR 
(neat): 2982, 2951, 2909, 1740, 1697, 1636, 1620, 1258, 1219, 1057, 
1026. ESIMS m/z: 443 (M + Na). HRMS–ESI (m/z): [M + Na]+ calcd for 
C27H32O4Na, 443.2193; found, 443.2197. [#]25D –7.5 (c 1.00, CHCl3). The 
(E)-geometry was assigned by analogy. 
(Z)-Isobutyl Methyl 2-Benzylidenemalonate (3ba). Table 2, entry 2: 
from 0.5-mmol 2b, the title compound (93.1 mg, 72%) was obtained as a 
pale yellow oil after purification by column chromatography (hexane to 
hexane/Et2O 50:1). Table 3, entry 1: from 0.5-mmol 4a, the title 
compound (65.8 mg, 48%) was obtained as a pale yellow oil after 
purification by column chromatography (hexane to hexane/Et2O 50:1): 1H 
NMR: 7.77 (s. 1H), 7.30–7.50 (m, 5H), 4.04 (d, J = 7.0, 2H), 3.85 (s, 3H), 
1.95 (nonet, J = 7.0, 1H), 0.87 (d, J = 7.0, 6H). 13C NMR: 166.8 (C), 
164.6 (C), 142.6 (CH), 132.9 (C), 130.5 (CH), 129.3 (CH), 128.8 (CH), 
126.0 (C), 71.9 (CH2), 52.6 (CH3), 27.4 (CH), 18.9 (CH3). IR (neat): 2957, 
1730, 1630, 1261, 1211, 1202, 1087, 1063. EIMS m/z: 262 (M+), 206 (M 
" isobutene), 189 (M " Oi-Bu). HRMS–ESI (m/z): [M + Na]+ calcd for 
C15H18O4Na, 285.1097; found, 285.1094. The (Z)-geometry was 
confirmed by NOESY correlation between the methyl protons of the 
isobutoxy group (0.87 ppm) and the aromatic protons (7.30–7.50 ppm). 
(Z)-Benzyl Methyl 2-Benzylidenemalonate (3ca): Purified by column 
chromatography (hexane to hexane/AcOEt 10/1). From 0.5-mmol 2c, the 
title compound (106 mg, 67%) was obtained as a pale yellow oil: 1H 
NMR: 7.79 (s, 1H), 7.46–7.31 (m, 10H), 5.30 (s, 2H), 3.83 (s, 3H). 13C 
NMR: 166.4 (C), 164.4 (C), 143.0 (CH), 134.8 (C), 132.6 (C), 130.5 (CH), 
129.4 (CH), 128.8 (CH), 128.7 (CH), 128.5 (CH), 127.9 (CH), 125.5 (C), 
67.5 (CH2), 52.6 (CH3). IR (KBr): 3021, 1701, 1670, 1261, 1215, 770, 756, 
696, 669. ESIMS m/z: 319 (M+Na). HRMS–ESI (m/z): [M + Na]+ calcd for 
C18H16O4Na, 319.0941; found, 319.0945. 1H and 13C NMR are in good 
agreement with those reported.[4b] 
(E)-Isobutyl 2-(Dimethylcarbamoyl)-3-phenylacrylate (3db): Purified 
by column chromatography (hexane/AcOEt 20:1 to 1:2). From 0.5-mmol 
2d, the title compound (101 mg, 74%) was obtained as a pale yellow oil: 
1H NMR: 7.68 (s, 1H), 7.50 (dd, J = 1.5, 5.0, 2H), 7.34–7.42 (m, 3H), 
3.96–4.10 (br m, 2H), 3.09 (s, 3H), 2.85 (s, 3H), 2.02 (nonet, J = 6.5, 1H), 
0.95 (d, J = 6.6, 6H). 13C NMR: 167.2 (C), 164.7 (C), 140.4 (CH), 133.1 
(C), 130.4 (CH), 129.6 (CH), 128.9 (CH), 127.8 (C), 71.4 (CH2), 37.5 
(CH3), 34.6 (CH3), 27.7 (CH), 19.0 (CH3). IR (neat): 2963, 1713, 1639, 
1246, 1196, 1153. EIMS m/z: 219 (M " isobutene). HRMS–ESI (m/z): [M 
+ H]+ calcd for C16H22NO3, 276.1600; found, 276.1595. Anal. Calcd for 
C16H21NO3: C, 69.79; H, 7.69; N, 5.09. Found: C, 69.69; H, 7.68; N, 4.83. 
The (E)-geometry was assigned by analogy. 
(E)-Isobutyl 2-Cyano-3-phenylacrylate (3eb): Purified by column 
chromatography (hexane/AcOEt 50:1 to 20:1). From 0.5-mmol 2e, the 
title compound (111 mg, 89%) was obtained as a white solid of mp 38–
39 °C: 1H NMR: 8.26 (s, 1H), 8.00 (d, J = 7.0, 2H), 7.57 (t, J = 7.0, 1H), 
7.51 (t, J = 7.0, 2H), 4.11 (d, J = 6.5, 2H), 2.09 (nonet, J = 6.5, 1H), 1.03 
(d, J = 6.5, 6H). 13C NMR: 162.4 (C), 154.9 (CH), 133.2 (CH), 131.4 (C), 
131.0 (CH), 129.2 (CH), 115.3 (C), 102.9 (C), 72.4 (CH2), 27.7 (CH), 18.9 
(CH3). IR (neat): 2967, 2222, 1724, 1609, 1265, 1188. EIMS m/z: 229 
(M+), 173 (M " isobutene). HRMS–ESI (m/z): [M + H]+ calcd for 






C14H16NO2, 252.0995; found, 252.0990. The (E)-geometry was assigned 
by analogy. 
(E)-Isobutyl Methyl 2-(4-Fluorobenzylidene)malonate (3fb): Purified 
by column chromatography (hexane/AcOEt 20:1 to 5:1). From 0.5-mmol 
2f, the title compound (133 mg, 90%) was obtained as a pale yellow oil: 
1H NMR: 7.70 (s, 1H), 7.44 (ddt, J = 8.5, 5.0, 2.5, 2H), 7.09 (tt, J = 8.5, 
2.5, 2H), 4.03 (d, J = 6.5, 2H), 3.86 (s, 3H), 2.01 (nonet, J = 6.5, 1H), 
0.97 (d, J = 6.5, 6H). 13C NMR: 166.0 (d, JC–F = 271, C), 163.9 (C), 162.9 
(C), 141.1 (CH), 131.5 (d, JC–F = 9, CH), 129.0 (C), 125.7 (C), 116.1 (d, 
JC–F = 22, CH), 71.6 (CH2), 52.6 (CH3), 27.7 (CH), 19.0 (CH3). IR (neat): 
3005, 2970, 1736, 1369, 1219. EIMS m/z: 280 (M+), 224 (M " isobutene). 
HRMS–ESI (m/z): [M + Na]+ calcd for C15H17FO4Na, 303.1003; found, 
303.1002. The (E)-geometry was assigned by analogy. 
(E)-Isobutyl Methyl 2-(4-Methoxybenzylidene)malonate (3gb): 
Purified by column chromatography (hexane/AcOEt 20:1 to 5:1). From 
0.5-mmol 2g, the title compound (112 mg, 76%) was obtained as a pale 
yellow oil: 1H NMR: 7.69 (s, 1H), 7.40 (dt, J = 9.0, 3.0, 2H), 6.90 (dt, J = 
9.0, 3.0, 2H), 4.02 (d, J = 6.5, 2H), 3.87 (s, 3H), 3.84 (s, 3H), 2.00 (m, 
1H), 0.96 (d, J = 7.0, 6H). 13C NMR: 167.7 (C), 164.4 (C), 161.6 (C), 
142.1 (CH), 131.5 (CH), 125.3 (C), 123.2 (C), 114.4 (CH), 71.4 (CH2), 
55.4 (CH3), 52.5 (CH3), 27.8 (CH), 19.0 (CH3). IR (neat) 2963, 2901, 
2847, 1717, 1601, 1512, 1258, 1173. EIMS m/z: 292 (M+), 219 (M " Oi-
Bu). HRMS–ESI (m/z): [M + Na]+ calcd for C16H20O5Na, 315.1203; found, 
315.1202. The (E)-geometry was assigned by analogy. 
(E)-Isobutyl Methyl 2-(2-Methylbenzylidene)malonate (3hb): Purified 
by column chromatography (hexane/Et2O 50:1 to 5:1). From 0.5-mmol 2h, 
the title compound (93.6 mg, 70%) was obtained as a pale yellow oil: 1H 
NMR: 7.99 (s, 1H), 7.32 (d, J = 7.5, 1H), 7.28 (t, J = 7.5, 1H), 7.21 (d, J = 
7.5, 1H), 7.17 (t, J = 7.5, 1H), 4.04 (d, J = 6.5, 2H), 3.74 (s, 3H), 2.38 (s, 
3H), 2.02 (nonet, J = 6.5, 1H), 0.97, (d, J = 6.5, 6H). 13C NMR: 166.9 (C), 
163.9 (C), 141.8 (CH), 137.7 (C), 132.5 (C), 130.5 (CH), 130.1 (CH), 
127.6 (CH), 127.2 (C), 126.1 (CH), 71.5 (CH2), 52.3 (CH3), 27.7 (CH), 
19.9 (CH3), 19.0 (CH3). IR (neat): 3021, 2963, 2874, 1724, 1254, 1215, 
1069. EIMS m/z: 277 (M " Me), 261 (M " OMe). HRMS–ESI (m/z): [M + 
H]+ calcd for C16H21O4, 277.1434; found, 277.1436. The (E)-geometry 
was assigned by analogy. 
(E)-Isobutyl Methyl 2-(2-Phenylethylidene)malonate (3ib): Purified by 
column chromatography (silica gel DIOL, hexane to hexane/AcOEt 5:1). 
From the mixture including 0.68-mmol 2i (347 mg), the title compound 
(107 mg, 57%) was obtained as a pale yellow oil: 1H NMR: 7.32 (t, J = 
7.0, 2H), 7.25 (m, 1H), 7.22 (t, J = 7.0, 2H), 7.11 (t, J = 8.0, 1H), 3.96 (d, 
J = 6.5, 2H), 3.86 (s, 3H), 3.64 (d, J = 8.0, 2H), 1.96 (nonet, J = 6.5, 1H), 
0.93 (d, J = 6.5, 6H). 13C NMR: 165.8 (C), 163.8 (C), 147.2 (CH), 137.0 
(C), 128.75 (CH), 128.70 (CH), 128.5 (C), 126.8 (CH), 71.3 (CH2), 52.2 
(CH3), 35.9 (CH2), 27.6 (CH), 18.9 (CH3). IR (neat): 2990, 2955, 29905, 
1724, 1643, 1601, 1366, 1250, 1231, 1200, 1065. EIMS m/z: 276 (M+), 
203 (M " Oi-Bu). Anal. Calcd for C16H20O4: C, 69.54; H, 7.30. Found: C, 
69.46; H, 7.37. The yield was calculated on the basis of the two-step 
yield (39%) and the estimated yield of 2i (69%). The (E)-geometry was 
assigned by analogy. 
(E)-Isobutyl Methyl 2-Heptylidenemalonate (3jb): Purified by column 
chromatography (hexane to hexane/AcOEt 50/1). From 0.5-mmol 2j, the 
title compound (107 mg, 79%) was obtained as a pale yellow oil: 1H 
NMR: 7.02 (t, J = 7.5, 1H), 3.96 (d, J = 6.5, 2 H), 3.82, (s, 3H), 2.30 (q, J 
= 7.5, 2H), 1.97 (nonet, J = 6.5, 1H), 1.44–1.50 (m, 2H), 1.23–1.40 (m, 
6H), 0.94 (d, J = 6.5, 6H), 0.88 (t, J = 6.9, 3H). 13C NMR: 166.1 (C), 
164.0 (C), 150.1 (CH), 128.2 (C), 71.2 (CH2), 52.1 (CH3), 31.5 (CH2), 
29.8 (CH2), 28.9 (CH2), 28.2 (CH2), 27.7 (CH), 22.5 (CH2), 19.0 (CH3), 
14.0 (CH3). IR (neat): 2955, 2928, 1724, 1643, 1605, 1246, 1227, 1065. 
EIMS m/z: 271 (M + H), 239 (M " OMe). HRMS–ESI (m/z): [M + H]+ 
calcd for C15H27O4, 271.1904; found, 271.1906. The (E)-geometry was 
assigned by analogy. 
(Z)-((1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl) Methyl 2-
Benzylidenemalonate (3ka): Purified by column chromatography 
(hexane to hexane/AcOEt 20/1). From 2.22-mmol 4a, the title compound 
(370 mg, 48%) was obtained as a white solid of mp 92–94 °C: 1H NMR: 
7.72 (s, 1H), 7.52–7.47 (m, 2H), 7.43–7.34 (m, 3H), 4.88 (dt, J = 4.5, 11.0, 
1H), 3.83 (s, 3H), 2.16 (m, 1H), 1.85 (d sextet, 1H, J = 2.5, 7.0, 1H), 
1.72–1.65 (m, 2H), 1.52 (m, 1H), 1.39 (ddt, J = 12.5, 11.0, 1.0, 1H), 1.13–
0.95 (m, 2H), 0.93 (d, J = 6.5, 3H), 0.88 (m, 1H), 0.82 (d, J = 7.0, 3H), 
0.77 (d, J = 3.0, 3H). 13C NMR: 166.4 (C), 164.7 (C), 141.8 (CH), 132.8 
(C), 130.5 (CH), 129.5 (CH), 128.7 (CH), 126.5 (C), 76.1 (CH), 52.4 
(CH3), 46.8 (CH3), 40.0 (CH2), 34.1 (CH2), 31.4 (CH), 25.5 (CH), 23.0 
(CH2), 22.0 (CH), 20.7 (CH3), 15.8 (CH3). [#]25D "40.2 (c 1.00, CHCl3). IR 
(neat): 2951, 2920, 1728, 1628, 1454, 1258, 1200, 1065, 764. ESIMS 
m/z: 367 (M + Na). HRMS–ESI (m/z): [M + Na]+ calcd for C21H28O4Na, 
367.1880; found, 367.1882. The (Z)-geometry was assigned by analogy. 
(Z)-1-((1R,2S,5R)-(2-Phenylpropan-2-yl)-5-methylcyclohexyl) 3-
Methyl 2-Benzylidenemalonate (3la): Purified by column 
chromatography (hexane to hexane/AcOEt 10:1). From 2.2-mmol 4a, the 
title compound (430 mg, 45%) was obtained as a colorless oil. 1H NMR: 
7.71 (s, 1H), 7.49 (dd, J = 7.5, 2.0, 2H), 7.41–7.17 (m, 7H), 7.10 (dt, J = 
7.0, 2.0, 1H), 4.92 (dt, J = 4.0, 10.5, 1H), 3.84 (s, 3H), 2.21 (ddd, J = 3.0, 
5.5, 11.5, 1H), 1.85 (ddd, J = 3.5, 9.0, 12.0, 1H), 1.53–1.43 (m, 2H), 1.28 
(m, 1H), 1.20 (s, 3H), 1.17 (s, 3H), 0.98–0.66 (m, 3H), 0.86 (d, J = 6.5, 
3H). 13C NMR: 165.8 (C), 164.4 (C), 150.7 (C), 142.1 (CH), 132.9 (C), 
130.3 (CH), 129.5 (CH), 128.5 (CH), 127.8 (CH), 126.6 (C), 125.4 (CH), 
125.1 (CH), 76.7 (CH), 52.3 (CH3), 50.4 (CH), 40.4 (CH2), 40.0 (CH2), 
34.3 (CH3), 31.2 (CH), 28.8 (CH), 27.2 (CH2),  23.4 (CH3), 21.7 (CH3). IR 
(neat): 2947, 1721, 1697, 1261, 1207, 1053. ESIMS m/z: 443 (M + Na). 
HRMS–ESI (m/z): [M + Na]+ calcd for C27H32O4Na, 443.2193; found, 
443.2192. [!]25D –31.3 (c 1.00, CHCl3). The (Z)-geometry was assigned 
by analogy. 
(E)-Isobutyl Methyl 2-(2-Methylpropylidene)malonate (3mb): 
according to the one-pot procedure for 3ab using 0.75-mmol 1m in place 
of 1a, the title compound (109 mg, 63%) was obtained as a pale yellow 
oil. 1H NMR: 6.68 (d, J = 10.0, 1H), 3.96 (d, J = 6.5, 2H), 3.82 (s, 3H), 
2.67 (m, 1H), 1.97 (nonet, J = 6.5, 1H), 1.07 (d, J = 6.5, 6H), 0.94 (d, J = 
6.5, 6H). 13C NMR: 166.2 (C), 164.1 (C), 155.4 (CH), 126.2 (C), 71.2 
(CH2), 52.1 (CH3), 29.5 (CH), 27.7 (CH), 21.8 (CH3), 19.0 (CH3). IR (KBr): 
2963, 2932, 2874, 1732, 1647, 1248, 1223, 1150, 1055, 999. EIMS m/z: 
172 (M – isobutene), 155 (M – Oi-Bu), 131, 122, 103, 91. HRMS–ESI 
(m/z): [M + Na]+ calcd for C12H20O4Na, 251.1254; found 251.1251, The 
(E)-geometry was assigned by analogy.  
(E)-Isobutyl Methyl 2-(2,2-Dimethylpropylidene)malonate (3nb): 
according to the one-pot procedure for 3ab using 1.5-mmol 1n in place of 
1a, the title compound (163 mg, 45%) was obtained as a pale yellow oil. 
1H NMR: 6.91 (s, 1H), 3.95 (d, J = 6.5, 2H), 3.81 (s, 3H), 1.94 (m, 1H), 
1.13 (s, 9H), 0.93 (d, J = 6.5, 6H). 13C NMR: 167.5 (C), 164.4 (C), 155.4 
(CH), 128.3 (C), 71.3 (CH2), 52.1 (CH3), 34.2 (CH), 28.8 (CH3), 27.7 (C), 
18.9 (CH3). IR (KBr): 2961, 2934, 2874, 1732, 1643, 1246, 1196, 1070, 
1001. EIMS m/z: 186 (M – isobutene), 171, 136, 105, 91. HRMS–ESI 
(m/z): [M + Na]+ calcd for C13H22O4Na, 265.1410; found 265.1406, The 
(E)-geometry was assigned by analogy. 
(Z)-Methyl 3-Phenyl-2-(tributylstannyl)acrylate (4a): 1a (1.5 mL, 10 
mmol) was placed in a dry 100-mL round-bottom flask. To the flask were 
added THF (10 mL), Bu3SnH (3.0 mL, 11 mmol), and AIBN (25 mg, 0.15 
mmol). The mixture was stirred for 3 h, and then concentrated in vacuo. 






The residue was purified by column chromatography (hexane to 
hexane/AcOEt 50:1) to afford the title compound (3.13 g, 69%) as a 
colorless oil: 1H NMR: 8.37 (s, 1H), 7.2–7.4 (m, 5H), 3.78 (s, 3H), 1.10–
1.51 (m, 12H), 0.7–0.9 (m, 15H). 13C NMR: 172.3 (C), 153.8 (CH), 139.2 
(C), 138.7 (C), 128.5 (CH), 128.1 (CH), 127.9 (CH), 51.7 (CH3), 28.8 
(CH2), 27.1 (CH2), 13.6 (CH3), 11.7 (CH2). IR (neat): 2955, 2922, 2870, 
2853, 1710, 1695, 1230, 1194, 1074. EIMS m/z: 451 (M+), 395 (M " Bu). 
The Z-geometry was confirmed by the H–Sn coupling constant of the "-H 
(8.37 ppm, 3JH–Sn = 100 Hz).[13] 1H NMR and 13C NMR were in good 
agreement with the published data.[29] 
(2SR,3SR,4SR,5SR)- and (2SR,3SR,4RS,5SR)-4-Benzyl 2,4-Dimethyl 
3,5-Diphenylpyrrolidine-2,4,4-tricarboxylate (6): Conducted according 
to the reported procedure[15] using 3ac (0.20 mmol). Purification of the 
crude material by column chromatography (hexane/AcOEt 10:1 to 1:1) 
gave the title compound (87 mg, 92%) as a pale-yellow oil: 1H NMR: 7.49 
(dt, J = 2.0, 8.5, 2H), 7.37–7.18 (m, 11H), 6.94 (dd, J = 2.0, 7.0, 0.72H), 
6.84 (dd, J = 2.0, 7.0, 1.28H), 5.37 (s, 0.36H), 5.35 (s, 0.64H), 4.91 (d, J 
= 7.5, 0.64H), 4.88 (d, J = 7.5, 0.36H), 4.45 (d, J = 6.5, 0.64H), 4.43 (d, J 
= 6.5, 0.36H), 4.24–4.21 (m, 1.36H), 4.12 (d, J = 12.5, 0.64H), 3.77 (s, 
3H), 3.12 (s, 2.16H), 3.10 (s, 1.08H). 13C NMR: 174.2 (minor C), 173.1 
(major C), 169.8 (minor C), 169.34 (minor C), 169.25 (major C), 169.1 
(major C), 138.6 (minor C), 138.5 (major C), 138.2 (minor C), 138.1 
(major C), 134.9 (minor C), 134.7 (major C), 128.9 (CH), 128.8 (CH), 
128.7 (CH), 128.45 (CH), 128.36 (CH), 128.30 (CH), 128.25 (CH), 
128.17 (CH), 128.15 (CH), 128.04 (CH), 127.98 (CH), 127.8 (CH), 
127.68 (CH), 127.65 (CH), 127.6 (CH), 127.53 (CH), 127.46 (CH), 79.72 
(major CH2), 79.66 (minor CH2), 71.3 (major C), 71.2 (minor C), 68.23 
(minor CH), 68.17 (major CH), 67.1 (major CH), 67.0 (minor CH), 66.3 
(minor CH), 66.1 (major CH), 56.3 (major CH3), 56.2 (minor CH3), 52.5 
(major CH3), 51.7 (minor CH3). IR (KBr): 3435, 2954, 2927, 1719, 1630, 
1437, 1383, 1265, 1213, 905, 733, 702, 650. ESIMS m/z: 474 (M + H). 
HRMS–ESI (m/z): [M + H]+ calcd for C28H28NO6, 474.1911; found, 
474.1914. The diastereomeric ratio (64:36) was determined by the 
integration area of 1H NMR signals at 6.94 ppm and 6.84 ppm. The 
relative configuration was determined after conversion into the known 
trimethyl ester with the established stereochemistry as follows. The 
stereochemistry of the quaternary carbon was not determined. 
Determination of the Relative Configuration of 6. Trimethyl 
(2SR,3SR,5SR)-3,5-Diphenylpyrrolidine-2,4,4-tricarboxylate: A 
mixture of 6 (30.0 mg, 0.063 mmol) and 10% Pd/C (6 mg, 0.1 equiv) in a 
5:1 mixture of THF/MeOH (2 mL) was stirred for 4 h at rt under H2 
atmosphere. The mixture was filtered through celite, which was 
successively washed with THF. To the combined filtrate, was added 1 M 
THF solution of TMSCHN2 (1.2 mmol, 20 equiv). After 15 min, the mixture 
was concentrated in vacuo to give the title compound (24.0 mg, 92%) as 
a yellow oil: 1H NMR: 7.47 (d, J = 7.5, 2H), 7.36‒7.14 (m, 8H), 5.33, (s, 
1H), 4.42 (d, J = 7.0, 1H), 4.24 (d, J = 7.0, 1H), 3.77 (s, 3H), 3.17 (s, 3H), 
3.13 (s, 3H). 1H NMR is in good agreement with that reported.[30] 
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